Staffan Holmberg-Thydén

4PUBLICATIONS
31CO-AUTHORS
Medical mycologyInnate immunityGene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 12, 2022
Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine.

Casey L O'Connell, Maria R Baer, Andreas Due Ørskov

|Oct 08, 2022
Neoantigen reactive T cells correlate with the low mutational burden in hematological malignancies.

Sunil Kumar Saini, Staffan Holmberg-Thydén, Anne-Mette Bjerregaard

|Jul 04, 2021
Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trial.

Staffan Holmberg-Thydén, Inge Høgh Dufva, Anne Ortved Gang

|Nov 10, 2020
Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers.

Sunil Kumar Saini, Andreas Due Ørskov, Anne-Mette Bjerregaard

Pageof 1

Frequent Collaborators

3 joint publications

Sine Reker Hadrup

2 joint publications

Andreas Due Ørskov

2 joint publications

Anne-Mette Bjerregaard

2 joint publications

Ashwin Unnikrishnan